Table 3.
Mortality risk associated with late non-fasting plasma glucose (dichotomous) in 5564 participants, stratified by HbA1c.
| HbA1c | CVD mortality | All-cause mortality | ||
|---|---|---|---|---|
| HRa (95% CI) | P value | HRa (95% CI) | P value | |
| Plasma glucose ≥ 105 vs < 105 mg/dL | ||||
| < 5.7% | 2.61 (1.99–3.44) | < 0.001 | 1.22 (1.01–1.47) | 0.037 |
| 5.7%-6.4% | 1.48 (1.05–2.07) | 0.023 | 1.37 (1.12–1.68) | 0.002 |
| ≥ 6.5% | 1.21 (0.71–2.04) | 0.488 | 1.13 (0.84–1.52) | 0.422 |
| Plasma glucose ≥ 110 vs < 110 mg/dL | ||||
| < 5.7% | 2.11 (1.51–2.94) | < 0.001 | 1.20 (0.95–1.53) | 0.131 |
| 5.7%-6.4% | 1.64 (1.08–2.50) | 0.020 | 1.55 (1.21–1.99) | 0.001 |
| ≥ 6.5% | 0.95 (0.58–1.57) | 0.845 | 1.01 (0.76–1.34) | 0.945 |
| Plasma glucose ≥ 115 vs < 115 mg/dL | ||||
| < 5.7% | 3.50 (2.28–5.38) | < 0.001 | 1.58 (1.14–2.19) | 0.006 |
| 5.7%-6.4% | 1.82 (1.08–3.07) | 0.024 | 1.74 (1.29–2.37) | < 0.001 |
| ≥ 6.5% | 0.91 (0.56–1.47) | 0.688 | 1.06 (0.80–1.40) | 0.677 |
CI, confidence interval; CVD, cardiovascular disease; HbA1c, hemoglobin A1c; HR, hazard ratio.
aAdjusted for age, sex, ethnicity, obesity, education, poverty-income ratio, survey period, physical activity, alcohol consumption, smoking status, self-reported hypertension, self-reported hypercholesterolemia, and natural log-transformed HbA1c.